Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
159.66
-0.46 (-0.29%)
At close: Oct 24, 2025, 4:00 PM EDT
162.50
+2.84 (1.78%)
After-hours: Oct 24, 2025, 7:50 PM EDT
Insmed Stock Forecast
Stock Price Forecast
The 17 analysts that cover Insmed stock have a consensus rating of "Strong Buy" and an average price target of $155.88, which forecasts a -2.37% decrease in the stock price over the next year. The lowest target is $109 and the highest is $240.
Price Target: $155.88 (-2.37%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Insmed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 10 |
| Buy | 8 | 8 | 8 | 8 | 8 | 7 |
| Hold | 0 | 0 | 0 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 19 | 19 | 19 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $140 → $194 | Strong Buy | Maintains | $140 → $194 | +21.51% | Oct 14, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $121 → $196 | Strong Buy | Maintains | $121 → $196 | +22.76% | Oct 3, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $154 → $193 | Strong Buy | Maintains | $154 → $193 | +20.88% | Oct 2, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $125 → $172 | Strong Buy | Maintains | $125 → $172 | +7.73% | Sep 8, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $140 → $171 | Buy | Maintains | $140 → $171 | +7.10% | Sep 3, 2025 |
Financial Forecast
Revenue This Year
480.38M
from 363.71M
Increased by 32.08%
Revenue Next Year
1.09B
from 480.38M
Increased by 125.86%
EPS This Year
-5.70
from -5.57
EPS Next Year
-3.68
from -5.70
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 523.1M | 1.4B | |||
| Avg | 480.4M | 1.1B | |||
| Low | 430.5M | 882.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 43.8% | 186.0% | |||
| Avg | 32.1% | 125.9% | |||
| Low | 18.4% | 83.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -5.20 | -2.49 | |||
| Avg | -5.70 | -3.68 | |||
| Low | -5.90 | -4.77 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.